|
参麦注射液治疗急性脑梗死的临床研究 |
| |
作者：张东涛 陈喜珊 何文贞
【关键词】 参麦
摘要：目的：观察参麦注射液治疗急性脑梗死（ACI）的疗效和血液粘稠度的关系。方法：急性脑梗塞86例，随机分为两组：两组患者除给予常规治疗外，治疗组给予参麦注射液50ml静脉滴注，每日一次。对照组给予复方丹参20ml加入生理盐水250ml中静脉滴注，每日一次。两组患者均治疗15d后进行疗效评定，并对治疗前后凝血酶原时间、纤维蛋白原、血小板粘附率及血脂等生化指标进行对比分析。结果：经一个疗程治疗后，治疗组基本治愈率68.2%，对照组35.7%，治疗组基本治愈率明显高于对照组（p<0.01）。各生化指标对比提示参麦注射液的抗凝降纤作用突出。结论：早期使用参麦注射液治疗急性脑梗塞是安全有效，且疗效优于复方丹参。
关键词：脑梗死；参麦注射液；复方丹参
Evaluating the Efficacy of Shenmai injection in Treating Patients with Cerebral Infarction
Abstract:Objective:To evaluate the treating effect of Shenmai injection in treating patients with cerebral infarction (CI). Method: 86 cases CI were randomly divided into two groups, in the Shenmai injection treating group 30 cases and compasitae radix salviae miltiorrhizae injection (CRSMI) control group 26 cases. Besides given roution treatment in all patients, the Shen Mai injection 50ml,iv drip,qd,in the treating group and 20ml CRSMI + 0.9%NS 500ml iv drip,qd,in the control group for 15 days . Result: After 15 days therapy, there were significant difference in the curative rate (68.2% vs 35.7% p<0.01) between treatment group and control group. Conclusion: Shenmai injection is an effective and safety medicine in treatment paralysis in patients with cerebral infarction .
Key words: Cerebral infarction; Shenmai injection; Compositae radix salviae miltiorrhizae
参麦注射液在临床上用于治疗脑梗死已见多篇报道。本文采用参麦注射液治疗急性脑梗死（ACI），并以复方丹参注射液体[1] [2] [3] 下一页
上一个医学论文： 不规则阴道出血患者沙眼衣原体和解脲脲原体感染136例临床分析
下一个医学论文： 重型颅脑损伤142例死亡原因探讨
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 儿科论文 >> 正文